Share this Story: Production delayed at federal government's new $126M COVID vaccine plant in MontrealProduction delayed at federal government's new $126M COVID vaccine plant in Montreal An official says the facility is ready, but Novavax’s vaccine is not yet approved for use in Canada and the company is still working on setting up production for its specific vaccine recipe Photo by Allen McInnis/Postmedia/FileArticle content OTTAWA – A $126 million plant in Montreal that the government hoped would be making COVID-19 vaccine by now is not yet up and running. Advertisement Story continues below This advertisement has not loaded yet, but your article continues below. Try refreshing your browser, or Production delayed at federal government's new $126M COVID vaccine plant in Montreal Back to video Early in the pandemic, the government gave the National Research Council $126 million to build a new Biologics Manufacturing Centre at the NRC’s existing facility in Montreal. Advertisement Story continues below This advertisement has not loaded yet, but your article continues below. The vaccine plant is the larger of two the government has set up at the NRC in Montreal since the pandemic began.

Source: National Post January 07, 2022 15:23 UTC